In conclusion, this study reveals that the 6xTg mouse is a promising new AD animal model that presents amyloid and tau pathology earlier than existing AD animal models and may be suitable for preclinical treatment studies of AD. The gene discussed is MAPT; the disease is Alzheimer disease.